Deutsche Bank
VIRX

Deutsche Bank’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Deutsche Bank’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6
Closed -$3K – 5494
2015
Q1 		$3K Buy
+6
New +$3.03K ﹤0.01% 4961
2014
Q4 		– Sell
-1
Closed -$1K – 6350
2014
Q3 		$1K Buy
+1
New +$1.45K ﹤0.01% 5789

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Deutsche Bank's VIRX Position: Q2 2023 in Review

Deutsche Bank sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q2 2023, closing a stake of 7,928 shares — an estimated $12.6K sold.

Deutsche Bank first reported a position in VIRX in Q2 2013 and held it in 22 quarters. The position peaked at $581K in Q2 2013. 41 funds tracked by Wall St. Rank hold VIRX as of Q2 2023.

  • Deutsche Bank reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Deutsche Bank sold 7,928 Viracta Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $12.6K.
  • Deutsche Bank first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
  • Deutsche Bank's Viracta Therapeutics, Inc. Common Stock position peaked at $581K in Q2 2013.
  • 41 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Deutsche Bank's 13F filing for Q2 2023, filed 14 Aug 2023.